Transfusion of red cells from donors with hereditary haemochromatosis improve haemoglobin increments in patients.
作者信息
Tsai Tsung-Lin, Chen Leonard N, Ma Ting-Lan, Conry-Cantilena Cathy, Flegel Willy A, West-Mitchell Kamille A
机构信息
Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Center for Health Professional Education, Uniformed Services University, Bethesda, Maryland, USA.
出版信息
Br J Haematol. 2023 Sep;202(5):1052-1054. doi: 10.1111/bjh.18951. Epub 2023 Jul 17.
Abstract
摘要
相似文献
1
Transfusion of red cells from donors with hereditary haemochromatosis improve haemoglobin increments in patients.
Br J Haematol. 2023 Sep;202(5):1052-1054. doi: 10.1111/bjh.18951. Epub 2023 Jul 17.
2
Interventions for hereditary haemochromatosis: an attempted network meta-analysis.
Cochrane Database Syst Rev. 2017 Mar 8;3(3):CD011647. doi: 10.1002/14651858.CD011647.pub2.
3
Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis.
Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s84-9. doi: 10.2450/2013.0128-13. Epub 2013 Oct 23.
4
[Erythrocytapheresis for hereditary haemochromatosis].
Ned Tijdschr Geneeskd. 2012;156(26):A4745.
5
Blood donation by healthy individuals with haemochromatosis.
N Z Med J. 2000 Mar 10;113(1105):77-8.
6
Pattern of care of blood donors with early-uncomplicated hereditary haemochromatosis in a Swiss blood donation centre.
Vox Sang. 2014 Feb;106(2):111-7. doi: 10.1111/vox.12078. Epub 2013 Sep 2.
7
[Importance of hereditary haemochromatosis in the care of diabetes mellitus].
Orv Hetil. 2007 Jan 21;148(3):111-5. doi: 10.1556/OH.2007.27901.
8
How we manage patients with hereditary haemochromatosis.
Br J Haematol. 2016 Dec;175(5):759-770. doi: 10.1111/bjh.14376. Epub 2016 Oct 10.
9
Hereditary haemochromatosis: patient support and education.
Nurs Stand. 2009;24(3):49-56. doi: 10.7748/ns2009.09.24.3.49.c7272.
10
Transfusion with blood from people with HFE gene mutations.
Lancet. 1999 Jul 31;354(9176):430. doi: 10.1016/S0140-6736(05)75854-2.
本文引用的文献
1
Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion.
Blood. 2019 Sep 26;134(13):1003-1013. doi: 10.1182/blood.2019000773. Epub 2019 Jul 26.
2
ACG Clinical Guideline: Hereditary Hemochromatosis.
Am J Gastroenterol. 2019 Aug;114(8):1202-1218. doi: 10.14309/ajg.0000000000000315.
3
Properties of donated red blood cell components from patients with hereditary hemochromatosis.
Transfusion. 2017 Jan;57(1):166-177. doi: 10.1111/trf.13890. Epub 2016 Nov 2.
4
The infectious disease blood safety risk of Australian hemochromatosis donations.
Transfusion. 2016 Dec;56(12):2934-2940. doi: 10.1111/trf.13802. Epub 2016 Sep 23.
5
Worldwide policies on haemochromatosis and blood donation: a survey among blood services.
Vox Sang. 2013 Aug;105(2):121-8. doi: 10.1111/vox.12038. Epub 2013 May 11.
6
Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.
Hepatology. 2011 Jul;54(1):328-43. doi: 10.1002/hep.24330.
7
Recommendations for the transfusion of red blood cells.
Blood Transfus. 2009 Jan;7(1):49-64. doi: 10.2450/2008.0020-08.
8
Hemochromatosis subjects as allogeneic blood donors: a prospective study.
Transfusion. 2003 Nov;43(11):1538-44. doi: 10.1046/j.1537-2995.2003.00570.x.
9
Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis.
JAMA. 2001 Sep 26;286(12):1475-81. doi: 10.1001/jama.286.12.1475.
10
Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content.
J Lab Clin Med. 2000 Jan;135(1):96-104. doi: 10.1016/s0022-2143(00)70026-6.
Zotero 插件